This brand name is authorized in Australia, Brazil, Germany, Estonia, Spain, Finland, France, Israel, Lithuania, Netherlands, Poland, Singapore, United Kingdom, South Africa
The drug NARAMIG contains one active pharmaceutical ingredient (API):
1
Naratriptan
UNII 10X8X4P12Z - NARATRIPTAN HYDROCHLORIDE
|
Naratriptan has been shown to be a selective agonist for 5 hydroxytryptamine1 (5-HT1) receptors mediating vascular contraction. This receptor is found predominantly in intracranial (cerebral and dural) blood vessels. Naratriptan is indicated for the acute treatment of migraine attacks with or without aura. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NARAMIG Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02CC02 | Naratriptan | N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8298R, 9734H |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510605201111316, 510614050051703 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 02465536, 08608801 |
Country: EE | Ravimiamet | Identifier(s): 1036459, 1076790, 1076802 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61828 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 489963 |
Country: FR | Base de données publique des médicaments | Identifier(s): 67586588 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 139356, 143217, 143218, 143219, 20113, 373616 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8161 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003095 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 48534 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100123308 |
Country: SG | Health Sciences Authority | Identifier(s): 09914P |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/7.3/0463 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.